Exact Sciences Announces First Quarter 2022 Results
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced that the company generated revenue of $486.6...
Source: prnewswire.com
📰 Science Therapy Selection Program News
Science Therapy Selection Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Science Therapy Selection Program. Real-time updates on events, politics, business and more.
Exact Sciences Announces Fourth Quarter 2021 Results
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced that the company generated revenue of $473.8...
Source: prnewswire.com
Exact Sciences and OncXerna Announce Licensing Agreement to Help Predict Immunotherapy Response for More Patients
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) and OncXerna Therapeutics, Inc., a precision medicine company, announced today they have entered an...
Ashleyr Robinson Matt Franklin Stephanie Spanos Laura Benjamin Megan Jones Precision Oncology For Exact Sciences
Source: prnewswire.com
Exact Sciences and OncXerna Announce Licensing Agreement to Help Predict Immunotherapy Response for More Patients
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) and OncXerna Therapeutics, Inc., a precision medicine company, announced today they have entered an...
Ashleyr Robinson Matt Franklin Stephanie Spanos Laura Benjamin Megan Jones Precision Oncology For Exact Sciences
Source: prnewswire.com